Veradigm Return on Investment 2010-2022 | MDRX
Current and historical return on investment (ROI) values for Veradigm (MDRX) over the last 10 years.
| Veradigm ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2022-12-31 | $-0.03B | $1.22B | -1.82% |
| 2022-09-30 | $0.06B | $1.38B | 3.93% |
| 2022-06-30 | $0.05B | $1.40B | 3.26% |
| 2022-03-31 | $0.08B | $1.73B | 4.31% |
| 2021-12-31 | $0.08B | $1.71B | 4.30% |
| 2021-09-30 | $0.11B | $1.79B | 6.26% |
| 2021-06-30 | $0.09B | $1.82B | 4.40% |
| 2021-03-31 | $0.04B | $1.85B | 2.20% |
| 2020-12-31 | $0.01B | $1.83B | 0.41% |
| 2020-09-30 | $-0.17B | $2.23B | -8.76% |
| 2020-06-30 | $-0.16B | $1.91B | -8.48% |
| 2020-03-31 | $-0.13B | $1.92B | -6.67% |
| 2019-12-31 | $-0.10B | $1.84B | -4.93% |
| 2019-09-30 | $-0.09B | $1.84B | -4.32% |
| 2019-06-30 | $-0.09B | $2.14B | -3.96% |
| 2019-03-31 | $-0.16B | $2.22B | -6.29% |
| 2018-12-31 | $-0.17B | $2.23B | -6.32% |
| 2018-09-30 | $-0.11B | $2.91B | -4.25% |
| 2018-06-30 | $-0.09B | $2.76B | -3.43% |
| 2018-03-31 | $-0.01B | $2.81B | -0.24% |
| 2017-12-31 | $0.01B | $2.07B | 0.50% |
| 2017-09-30 | $0.08B | $2.53B | 3.06% |
| 2017-06-30 | $0.07B | $2.48B | 2.73% |
| 2017-03-31 | $0.07B | $2.49B | 2.64% |
| 2016-12-31 | $0.07B | $2.58B | 2.82% |
| 2016-09-30 | $0.07B | $2.58B | 3.12% |
| 2016-06-30 | $0.06B | $2.52B | 2.94% |
| 2016-03-31 | $0.05B | $1.98B | 2.48% |
| 2015-12-31 | $0.03B | $2.03B | 1.62% |
| 2015-09-30 | $0.01B | $2.04B | 0.52% |
| 2015-06-30 | $-0.02B | $2.02B | -0.96% |
| 2015-03-31 | $-0.03B | $1.82B | -1.80% |
| 2014-12-31 | $-0.04B | $1.82B | -2.13% |
| 2014-09-30 | $-0.07B | $1.85B | -3.69% |
| 2014-06-30 | $-0.09B | $1.84B | -4.97% |
| 2014-03-31 | $-0.11B | $1.84B | -5.95% |
| 2013-12-31 | $-0.13B | $1.86B | -6.85% |
| 2013-09-30 | $-0.13B | $1.86B | -7.00% |
| 2013-06-30 | $-0.07B | $1.90B | -4.21% |
| 2013-03-31 | $-0.03B | $1.79B | -1.64% |
| 2012-12-31 | $0.01B | $1.65B | 0.76% |
| 2012-09-30 | $0.09B | $1.69B | 4.93% |
| 2012-06-30 | $0.11B | $1.70B | 6.29% |
| 2012-03-31 | $0.13B | $1.79B | 6.99% |
| 2011-12-31 | $0.14B | $1.80B | 7.55% |
| 2011-09-30 | $0.10B | $1.78B | 5.51% |
| 2011-06-30 | $0.07B | $1.79B | 3.54% |
| 2011-03-31 | $0.05B | $1.84B | 3.88% |
| 2010-09-30 | $0.05B | $1.88B | 11.09% |
| 2010-06-30 | $0.09B | 42.45% | |
| 2010-03-31 | $0.09B | 15.27% | |
| 2010-02-28 | $0.08B | $0.80B | 13.59% |
| 2009-09-30 | $0.07B | 11.51% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.482B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.989B | 58.51 |
| Hims & Hers Health (HIMS) | United States | $13.669B | 142.02 |
| Tempus AI (TEM) | United States | $11.962B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.646B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.825B | 59.77 |
| Hinge Health (HNGE) | United States | $3.100B | 0.00 |
| Privia Health (PRVA) | United States | $2.659B | 181.75 |
| Enovis (ENOV) | United States | $1.751B | 9.76 |
| Schrodinger (SDGR) | United States | $1.545B | 0.00 |
| Phreesia (PHR) | United States | $1.527B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Azenta (AZTA) | United States | $1.371B | 63.70 |
| 10x Genomics (TXG) | United States | $1.338B | 0.00 |
| Omnicell (OMCL) | United States | $1.324B | 23.36 |
| Claritev (CTEV) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.618B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.534B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| Outset Medical (OM) | United States | $0.347B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 766.67 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| Pulmonx (LUNG) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.107B | 4.06 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |